12/20
11:10 am
pyxs
Pyxis Oncology, Inc. (NASDAQ: PYXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock, down previously from $7.00.
Medium
Report
Pyxis Oncology, Inc. (NASDAQ: PYXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock, down previously from $7.00.
12/20
10:22 am
pyxs
Pyxis Oncology, Inc. (NASDAQ: PYXS) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $8.00 price target on the stock, down previously from $10.00.
Medium
Report
Pyxis Oncology, Inc. (NASDAQ: PYXS) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $8.00 price target on the stock, down previously from $10.00.
12/20
10:22 am
pyxs
Pyxis Oncology, Inc. (NASDAQ: PYXS) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $8.00 price target on the stock, down previously from $10.00.
Medium
Report
Pyxis Oncology, Inc. (NASDAQ: PYXS) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $8.00 price target on the stock, down previously from $10.00.
12/20
09:50 am
pyxs
Rating for PYXS
High
Report
Rating for PYXS
12/20
09:50 am
pyxs
Rating for PYXS
High
Report
Rating for PYXS
11/21
09:57 am
pyxs
Rating for PYXS
Medium
Report
Rating for PYXS
11/21
09:57 am
pyxs
Rating for PYXS
Medium
Report
Rating for PYXS
11/21
08:05 am
pyxs
Pyxis Oncology, Inc. (NASDAQ: PYXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
High
Report
Pyxis Oncology, Inc. (NASDAQ: PYXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
11/21
08:05 am
pyxs
Pyxis Oncology, Inc. (NASDAQ: PYXS) was downgraded by analysts at William Blair from an "outperform" rating to a "market perform" rating.
High
Report
Pyxis Oncology, Inc. (NASDAQ: PYXS) was downgraded by analysts at William Blair from an "outperform" rating to a "market perform" rating.
11/21
08:05 am
pyxs
Pyxis Oncology, Inc. (NASDAQ: PYXS) was downgraded by analysts at William Blair from an "outperform" rating to a "market perform" rating.
High
Report
Pyxis Oncology, Inc. (NASDAQ: PYXS) was downgraded by analysts at William Blair from an "outperform" rating to a "market perform" rating.
11/21
07:09 am
pyxs
Rating for PYXS
High
Report
Rating for PYXS
11/21
07:09 am
pyxs
Rating for PYXS
High
Report
Rating for PYXS
11/8
08:46 am
pyxs
Pyxis Oncology, Inc. (NASDAQ: PYXS) is now covered by analysts at Stephens. They set an "overweight" rating and a $13.00 price target on the stock.
Low
Report
Pyxis Oncology, Inc. (NASDAQ: PYXS) is now covered by analysts at Stephens. They set an "overweight" rating and a $13.00 price target on the stock.
11/8
08:46 am
pyxs
Pyxis Oncology, Inc. (NASDAQ: PYXS) is now covered by analysts at Stephens. They set an "overweight" rating and a $13.00 price target on the stock.
Low
Report
Pyxis Oncology, Inc. (NASDAQ: PYXS) is now covered by analysts at Stephens. They set an "overweight" rating and a $13.00 price target on the stock.
11/8
07:00 am
pyxs
Rating for PYXS
Medium
Report
Rating for PYXS